Answers are grounded in this paper and cite their sources.
Objective To learn the distribution of antinuclear antibodies (ANAs) in health check-up and the clinical visit populations, so as to provide evidence for the follow-up study of ANA positive individuals. Methods ANAs were measured by using indirect immunofluorescence assay (IIF). Fresh serum was extracted in accordance with reagent instructions each day.Fifteen specific antibodies were detected by Euroimmun blot.SPSS17.0 statistical software was used for data analysis. Results (1) For ANA>1∶100, the positive rate in health check-up or clinical visit population was 14.1% vs 43.3%.However, for ANA>1∶320, the positive rate in health check-up or clinical visit population was 5.9% vs 22.4%.(2) In the two tilter groups, ANA positive rate was consistent in different age groups.There were statistically significant differences of ANA positive rate in different gender groups: a smooth upward trend with age was found in male; however, two peaks were identified in female during the period of puberty and menopause.(3) The frequency of occurrence of fifteen specific antibodies was higher in the clinical visit group, although the occurrence of anti-M2 showed no difference between the two groups. Conclusions This investigation found a significant difference in ANA positive rate between health check-up populations and clinical visit patients.The positive rate of ANA may be changed with gender and age.ANAs screening in high risk populations could be important for the early diagnosis and intervention of autoimmune diseases.
No takes yet. Share an insight, caveat, or question.
Yaping et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: